Latest News & Research

Research finds every cigarette shortens life expectancy by about 20 minutes.

Smoking a single cigarette reduces life expectancy by about 20 minutes, according to a new analysis by researchers from the University College London.

Australian Prescriber article and podcast: Therapeutic vapes for smoking cessation and nicotine dependence

Quit Centre and Quit team members have authored this useful article, which has been published in December's Australian Prescriber.
A podcast is now available on this topic as well.

The role of nurses in smoking cessation interventions for patients

A newly published review highlights the critical role nurses play in smoking cessation interventions. Analysis of 53 articles indicated that nurses commonly engaged in smoking assessment with patients, but it was not common for nurses to receive training in smoking cessation interventions. Smoking cessation training will enable nurses to deliver effective smoking cessation interventions with patients.

Health professional consultation survey

Your insights are important to us and the responses contribute to planning the future work of Quit Centre. We welcome participation and feedback from general practitioners, nurse practitioners, primary care nurses and pharmacists.

New training module: Pharmacists delivering nicotine dependence treatment under vaping reforms

The ‘Pharmacists delivering nicotine dependence treatment under vaping reforms’ online training module is designed to support pharmacists on the new regulatory framework introduced by the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Act 2024.

Vaping reforms

From 1 July 2024 the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Act 2024 has changed the way vapes can be sourced, supplied and advertised.

From 1 October 2024 pharmacists will be able to supply vapes with a nicotine concentration of 20 mg/mL or less, to people 18 years or over without a prescription subject to certain conditions and state and territory law.

Cytisine for cessation

A final decision has been made on proposed amendments to the Poisons Schedule in relation to cytisine. The delegate of the Secretary of the Department of Health and Aged Care (the Delegate) made the decision to create new entries for cytisine in Schedules 3 and 4 and Appendix H. Currently there are no cytisine products on the Australian Register of Therapeutic Goods.